BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 11603814)

  • 1. Analysis of the TSC2 gene in human medulloblastoma.
    Przkora R; Meyer-Puttlitz B; Schmitt O; Berthold F; Nöthen M; Krauss J; Tonn JC; von Deimling A; Wiestler OD; Pietsch T
    Acta Neuropathol; 2001 Oct; 102(4):380-4. PubMed ID: 11603814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel splice site associated polymorphism in the tuberous sclerosis 2 (TSC2) gene may predispose to the development of sporadic gangliogliomas.
    Platten M; Meyer-Puttlitz B; Blümcke I; Waha A; Wolf HK; Nöthen MM; Louis DN; Sampson JR; von Deimling A
    J Neuropathol Exp Neurol; 1997 Jul; 56(7):806-10. PubMed ID: 9210877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in the TSC2 gene: analysis of the complete coding sequence using the protein truncation test (PTT).
    van Bakel I; Sepp T; Ward S; Yates JR; Green AJ
    Hum Mol Genet; 1997 Sep; 6(9):1409-14. PubMed ID: 9285776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutational analysis of TSC1 and TSC2 genes in gangliogliomas.
    Becker AJ; Löbach M; Klein H; Normann S; Nöthen MM; von Deimling A; Mizuguchi M; Elger CE; Schramm J; Wiestler OD; Blümcke I
    Neuropathol Appl Neurobiol; 2001 Apr; 27(2):105-14. PubMed ID: 11437991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular analysis of the TSC1 and TSC2 tumour suppressor genes in sporadic glial and glioneuronal tumours.
    Parry L; Maynard JH; Patel A; Hodges AK; von Deimling A; Sampson JR; Cheadle JP
    Hum Genet; 2000 Oct; 107(4):350-6. PubMed ID: 11129334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutational analysis of the tuberous sclerosis gene TSC2 in patients with pulmonary lymphangioleiomyomatosis.
    Astrinidis A; Khare L; Carsillo T; Smolarek T; Au KS; Northrup H; Henske EP
    J Med Genet; 2000 Jan; 37(1):55-7. PubMed ID: 10633137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tuberous sclerosis-like lesions in epileptogenic human neocortex lack allelic loss at the TSC1 and TSC2 regions.
    Wolf HK; Normann S; Green AJ; von Bakel I; Blümcke I; Pietsch T; Wiestler OD; von Deimling A
    Acta Neuropathol; 1997 Jan; 93(1):93-6. PubMed ID: 9006662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The GAP-related domain of tuberin, the product of the TSC2 gene, is a target for missense mutations in tuberous sclerosis.
    Maheshwar MM; Cheadle JP; Jones AC; Myring J; Fryer AE; Harris PC; Sampson JR
    Hum Mol Genet; 1997 Oct; 6(11):1991-6. PubMed ID: 9302281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the Max-binding protein MNT in human medulloblastomas.
    Sommer A; Waha A; Tonn J; Sörensen N; Hurlin PJ; Eisenman RN; Lüscher B; Pietsch T
    Int J Cancer; 1999 Sep; 82(6):810-6. PubMed ID: 10446446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular genetic and phenotypic analysis reveals differences between TSC1 and TSC2 associated familial and sporadic tuberous sclerosis.
    Jones AC; Daniells CE; Snell RG; Tachataki M; Idziaszczyk SA; Krawczak M; Sampson JR; Cheadle JP
    Hum Mol Genet; 1997 Nov; 6(12):2155-61. PubMed ID: 9328481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apparent preferential loss of heterozygosity at TSC2 over TSC1 chromosomal region in tuberous sclerosis hamartomas.
    Carbonara C; Longa L; Grosso E; Mazzucco G; Borrone C; Garrè ML; Brisigotti M; Filippi G; Scabar A; Giannotti A; Falzoni P; Monga G; Garini G; Gabrielli M; Riegler P; Danesino C; Ruggieri M; Magro G; Migone N
    Genes Chromosomes Cancer; 1996 Jan; 15(1):18-25. PubMed ID: 8824721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenesis of tuberous sclerosis subependymal giant cell astrocytomas: biallelic inactivation of TSC1 or TSC2 leads to mTOR activation.
    Chan JA; Zhang H; Roberts PS; Jozwiak S; Wieslawa G; Lewin-Kowalik J; Kotulska K; Kwiatkowski DJ
    J Neuropathol Exp Neurol; 2004 Dec; 63(12):1236-42. PubMed ID: 15624760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel mutations detected in the TSC2 gene from both sporadic and familial TSC patients.
    Wilson PJ; Ramesh V; Kristiansen A; Bove C; Jozwiak S; Kwiatkowski DJ; Short MP; Haines JL
    Hum Mol Genet; 1996 Feb; 5(2):249-56. PubMed ID: 8824881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of both TSC1 and TSC2 for germline mutations in 126 unrelated patients with tuberous sclerosis.
    Niida Y; Lawrence-Smith N; Banwell A; Hammer E; Lewis J; Beauchamp RL; Sims K; Ramesh V; Ozelius L
    Hum Mutat; 1999; 14(5):412-22. PubMed ID: 10533067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel TSC2 mutation in a patient with pulmonary tuberous sclerosis: lack of loss of heterozygosity in a lung cyst.
    Zhang H; Yamamoto T; Nanba E; Kitamura Y; Terada T; Akaboshi S; Yuasa I; Ohtani K; Nakamoto S; Takeshita K; Ohno K
    Am J Med Genet; 1999 Feb; 82(5):368-70. PubMed ID: 10069705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterozygosity for the tuberous sclerosis complex (TSC) gene products results in increased astrocyte numbers and decreased p27-Kip1 expression in TSC2+/- cells.
    Uhlmann EJ; Apicelli AJ; Baldwin RL; Burke SP; Bajenaru ML; Onda H; Kwiatkowski D; Gutmann DH
    Oncogene; 2002 Jun; 21(25):4050-9. PubMed ID: 12037687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 34 bp deletion within TSC2 is a rare polymorphism, not a pathogenic mutation.
    Roberts PS; Ramesh V; Dabora S; Kwiatkowski DJ
    Ann Hum Genet; 2003 Nov; 67(Pt 6):495-503. PubMed ID: 14641237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tuberous sclerosis gene products in proliferation control.
    Hengstschläger M; Rodman DM; Miloloza A; Hengstschläger-Ottnad E; Rosner M; Kubista M
    Mutat Res; 2001 Jul; 488(3):233-9. PubMed ID: 11397651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct allelic variants of TSC1 and TSC2 in epilepsy-associated cortical malformations without balloon cells.
    Majores M; Blümcke I; Urbach H; Meroni A; Hans V; Holthausen H; Elger CE; Schramm J; Galli C; Spreafico R; Wiestler OD; Becker AJ
    J Neuropathol Exp Neurol; 2005 Jul; 64(7):629-37. PubMed ID: 16042315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of function of the tuberous sclerosis 2 tumor suppressor gene results in embryonic lethality characterized by disrupted neuroepithelial growth and development.
    Rennebeck G; Kleymenova EV; Anderson R; Yeung RS; Artzt K; Walker CL
    Proc Natl Acad Sci U S A; 1998 Dec; 95(26):15629-34. PubMed ID: 9861021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.